Literature DB >> 27484171

Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014.

Marcela Krutova1, Jana Matejkova, Ed J Kuijper, Pavel Drevinek, Otakar Nyc.   

Abstract

In 2014, 18 hospitals in the Czech Republic participated in a survey of the incidence of Clostridium difficile infections (CDI) in the country. The mean CDI incidence was 6.1 (standard deviation (SD):7.2) cases per 10,000 patient bed-days and 37.8 cases (SD: 41.4) per 10,000 admissions. The mean CDI testing frequency was 39.5 tests (SD: 25.4) per 10,000 patient bed-days and 255.8 tests (SD: 164.0) per 10,000 admissions. A total of 774 C. difficile isolates were investigated, of which 225 (29%) belonged to PCR ribotype 176, and 184 isolates (24%) belonged to PCR ribotype 001. Multilocus variable-number tandem repeat analysis (MLVA) revealed 27 clonal complexes formed by 84% (190/225) of PCR ribotype 176 isolates, and 14 clonal complexes formed by 77% (141/184) of PCR ribotype 001 isolates. Clonal clusters of PCR ribotypes 176 and 001 were observed in 11 and 7 hospitals, respectively. Our data demonstrate the spread of two C. difficile PCR ribotypes within 18 hospitals in the Czech Republic, stressing the importance of standardising CDI testing protocols and implementing mandatory CDI surveillance in the country. This article is copyright of The Authors, 2016.

Entities:  

Keywords:  C. difficile infection; CDI surveillance; MLVA; PCR ribotype 001; PCR ribotype 176; binary toxin; ribotyping

Mesh:

Year:  2016        PMID: 27484171     DOI: 10.2807/1560-7917.ES.2016.21.29.30296

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

1.  Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.

Authors:  M Krutova; J Matejkova; P Drevinek; E J Kuijper; O Nyc
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-05       Impact factor: 3.267

2.  The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.

Authors:  Marcela Krutova; Vaclav Capek; Elka Nycova; Sabina Vojackova; Magda Balejova; Lenka Geigerova; Renata Tejkalova; Lenka Havlinova; Iva Vagnerova; Pavel Cermak; Lenka Ryskova; Petr Jezek; Dana Zamazalova; Denisa Vesela; Alice Kucharova; Dana Nemcova; Martina Curdova; Otakar Nyc; Pavel Drevinek
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-30       Impact factor: 4.887

3.  Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil.

Authors:  Amanda Nadia Diniz; Loren Nery Fontoura Moura; Diogo Soares Gonçalves Cruz; Carlos Augusto Oliveira Junior; Henrique César Pereira Figueiredo; João Luís Reis Cunha; Eduardo Garcia Vilela; Edward J Kuijper; Mark H Wilcox; Francisco Carlos Faria Lobato; Rodrigo Otávio Silveira Silva
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

4.  Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové.

Authors:  Kristýna Vaverková; Martin Kracík; Lenka Ryšková; Pavla Paterová; Rudolf Kukla; Lenka Hobzová; Roman Špánek; Helena Žemličková
Journal:  Antibiotics (Basel)       Date:  2021-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.